+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug Testing Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Drug Testing Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
New

Drug Testing Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 181 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6082432
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Drug Testing Market grew from USD 24.94 billion in 2024 to USD 28.11 billion in 2025. It is expected to continue growing at a CAGR of 12.22%, reaching USD 49.83 billion by 2030.

The global drug testing market plays a pivotal role in safeguarding workplace safety, healthcare outcomes, legal compliance, and public health. Over the past decade, evolving regulatory frameworks and heightened awareness of substance abuse have driven steady demand for reliable testing solutions. Innovations in sample collection and analytical techniques have accelerated turnaround times while improving accuracy. Meanwhile, employers, healthcare providers, government agencies, and individuals increasingly rely on a diverse array of testing technologies to detect illicit and prescription drug use across a range of scenarios-from pre-employment and random screening to post-accident and return-to-duty evaluations.

As market dynamics shift, stakeholders face new opportunities and challenges. Advances in immunoassay, high-performance liquid chromatography, and gas chromatography-mass spectrometry are raising the bar for sensitivity and specificity. At the same time, regulatory changes in the United States and abroad are reshaping supply chains and cost structures. In this report, we provide an executive-level overview of these trends, highlighting transformative shifts, the impact of recently introduced U.S. tariffs, deep segmentation insights, regional patterns, competitive intelligence on leading players, and actionable recommendations. Our goal is to equip decision-makers with the knowledge needed to navigate this evolving landscape and capitalize on emerging growth avenues.

Transformative Shifts Reshaping the Drug Testing Landscape

The drug testing landscape is undergoing a profound transformation driven by technology, regulation, and changing stakeholder expectations. Point-of-care testing has moved from laboratory settings into clinics, workplaces, and even users’ homes, enabled by portable immunoassay devices and over-the-counter kits. Concurrently, analytical platforms such as GC-MS and HPLC are being integrated with advanced data analytics and machine learning to improve detection accuracy, reduce false positives, and streamline result interpretation.

Regulatory bodies are also adapting. Agencies are updating guidelines to address emerging synthetic drugs and novel psychoactive substances that challenge traditional assays. In parallel, digital health platforms and telemedicine services are creating new avenues for remote sample collection, chain-of-custody management, and secure result transmission. These technological and regulatory shifts are not only enhancing the reliability and accessibility of testing but are also expanding market reach into previously underserved segments, such as telehealth providers and rural healthcare networks.

Assessing the Cumulative Impact of U.S. Tariffs in 2025

In 2025, the United States implemented a series of tariffs on imported laboratory equipment, testing reagents, and pre-manufactured assay kits. These measures, targeting products sourced from major exporting regions, have had a cascading effect across the value chain. Domestic testing laboratories are experiencing higher input costs, leading to modest price increases for end users. Equipment manufacturers with overseas production facilities face delayed shipments and reconfigured logistics, prompting many to evaluate nearshoring or reshoring strategies.

Meanwhile, reagent suppliers and kit producers are redirecting sourcing to domestic or tariff-free markets, fostering new partnerships with local chemical manufacturers. While these adjustments carry short-term cost implications, they also present an opportunity to strengthen supply chain resilience and reduce reliance on volatile global trade routes. In parallel, the domestic manufacturing push is catalyzing investment in automation and advanced manufacturing technologies, which can ultimately improve scalability and cost efficiency.

Key Market Segmentation Insights Across Eleven Dimensions

Market segmentation reveals distinct dynamics across eleven critical dimensions. Type-of-drug-test demand is led by urine panels, though hair and saliva assays are growing rapidly due to noninvasive collection and detection of historical usage. Industry applications range from construction projects requiring rigorous safety protocols to government and law enforcement agencies prioritizing chain-of-custody integrity, through healthcare settings-both clinics and hospitals-addressing pre-surgical screenings and patient monitoring; manufacturing plants enforcing zero-tolerance policies; competitive sports organizations enforcing anti-doping regulations; and transportation sectors spanning aviation, maritime and road, each with unique regulatory requirements.

End-user profiles show large enterprises investing heavily in on-site testing to minimize downtime, while small and medium enterprises increasingly outsource to third-party providers for cost efficiency. Individuals seek direct-to-consumer options, and rehabilitation centers emphasize follow-up and return-to-duty testing to support recovery journeys. Purpose-of-testing categories include pre-employment screening to ensure safe work environments, random and post-accident testing for incident prevention, follow-up tests to verify abstinence, and return-to-duty evaluations to reintegrate employees after treatment.

Drug-type segmentation highlights amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine, and opiates as primary targets, with synthetic opioids and designer stimulants emerging as next-generation concerns. Testing technologies span immunoassays for rapid screening, high-performance liquid chromatography for quantitative analysis, and gas chromatography-mass spectrometry for confirmatory testing. Testing channels include FDA-approved kits for regulatory compliance, centralized laboratory-based testing for high-throughput needs, and over-the-counter products for decentralized screening. Gender and age group analyses underscore differing prevalence patterns, with youth (0-17 years), young adults (18-35 years), adults (36-55 years) and seniors (56+ years) each exhibiting unique usage trends, and an anticipated future sub-segmentation addressing retirement age populations (65+).

Sample volume considerations distinguish between high-throughput clinical laboratories, medium-volume occupational health providers, and low-volume point-of-care settings. Finally, certification and standards such as CAP accreditation, CLIA compliance, and SAMHSA certification form the regulatory backbone that assures accuracy and legal defensibility across testing workflows. Together, these segmentation insights enable tailored strategies for product development, marketing positioning, and service delivery across diverse customer profiles.

Critical Regional Trends Shaping Market Expansion

Regional analysis underscores significant variations in adoption, regulation, and growth trajectories. In the Americas, robust employer-sponsored testing programs and proactive government regulations have established a large, mature market, with the United States leading in technological innovation and Latin America experiencing steady uptake driven by multinational workforce screening requirements.

Europe, Middle East & Africa present a heterogeneous picture: Western Europe maintains stringent regulatory standards and high per-capita testing rates, while emerging EMEA markets are expanding capacity to meet growing demand. Regulatory harmonization efforts in the European Union facilitate cross-border services, whereas in the Middle East and Africa, infrastructure development and public-private partnerships are accelerating market maturation.

Asia-Pacific is characterized by rapid growth, fueled by expanding manufacturing bases, transportation safety mandates, and increasing corporate governance standards in countries such as China, India, Japan, and Australia. Government initiatives to combat drug-related crime and improve workplace safety are translating into large-scale testing programs and substantial investments in laboratory infrastructure. Together, these regional insights inform market entry strategies, partnership opportunities, and geographic prioritization for product rollouts.

Competitive Landscape and Leading Company Strategies

Leading players in the drug testing arena are pursuing diverse strategies to consolidate market position and drive innovation. Abbott Laboratories leverages its immunoassay and rapid-testing expertise to expand point-of-care offerings, while Agilent Technologies, Inc. continues to enhance its GC-MS and HPLC platforms with advanced software integration. Alfa Scientific Designs, Inc. focuses on over-the-counter test development, tapping into direct-to-consumer channels.

Bio-Rad Laboratories, Inc. and Thermo Fisher Scientific Inc. are investing in modular laboratory solutions that can be rapidly deployed to emerging markets. Clinical Reference Laboratory, Inc. and Quest Diagnostics are fortifying their nationwide networks to provide seamless, high-throughput screening services, whereas Cordant Health Solutions and Legacy Medical Services, LLC. differentiate through specialized occupational health offerings. Drägerwerk AG & Co. KGaA and Siemens Healthineers AG emphasize integrated safety systems for industrial and transportation applications.

F. Hoffmann-La Roche AG is exploring partnerships in personalized medicine to incorporate drug-metabolite profiling, while Omega Laboratories, Inc. and Sciteck Clinical Laboratories invest in niche testing segments and specialized analyte panels. Quidel Corporation enhances rapid diagnostic assays, complementing laboratory-based testing channels. These competitive insights reveal how leading companies are aligning product roadmaps, strategic alliances and M&A activity to capture growth across key segments and geographies.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize several strategic initiatives to maintain competitive advantage. First, invest in point-of-care and decentralized testing solutions, leveraging immunoassay and over-the-counter channels to meet demand for rapid, on-demand results. Second, diversify supply chains by establishing partnerships with domestic reagent and equipment manufacturers to mitigate tariff-driven cost inflation and ensure continuity of operations.

Third, adopt advanced data analytics and digital health platforms to enhance result accuracy, streamline workflows and offer value-added services such as trend analysis and predictive risk assessments. Fourth, pursue targeted expansions into high-growth regional markets-particularly in Asia-Pacific-through joint ventures, distribution agreements and localized manufacturing. Fifth, strengthen compliance and accreditation efforts by aligning closely with CAP, CLIA and SAMHSA standards, demonstrating reliability and legal defensibility to enterprise and government customers.

Finally, explore M&A opportunities to acquire niche testing capabilities, emerging technologies and specialized market access, thereby broadening service portfolios and accelerating innovation cycles. These recommendations provide a roadmap for decision-makers seeking to navigate evolving regulatory landscapes, technological disruption, and shifting customer preferences.

Conclusion and Strategic Imperatives

The drug testing market stands at a crossroads of technological innovation, regulatory evolution and shifting stakeholder expectations. Advanced analytical platforms, point-of-care testing and digital health integration are redefining how and where tests are performed, while new U.S. tariffs are forcing a reevaluation of global supply chains. Comprehensive segmentation across test type, industry, end user, purpose, drug class, technology, channel, gender, age group, sample volume and certification highlights diverse growth pockets and service opportunities.

Regional variations in adoption and regulation underscore the need for tailored market entry and expansion strategies. Leading companies are responding by enhancing product portfolios, expanding service networks, and pursuing strategic partnerships. By embracing the actionable recommendations outlined-diversifying sourcing, investing in digital platforms, targeting high-growth regions, and securing accreditation-organizations can position themselves for sustainable growth in an increasingly competitive environment.

Market Segmentation & Coverage

This research report categorizes the Drug Testing Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Blood Test
  • Hair Test
  • Saliva Test
  • Sweat Test
  • Urine Test
  • Construction
  • Government And Law Enforcement
  • Healthcare
    • Clinics
    • Hospitals
  • Manufacturing
  • Sports
  • Transportation
    • Aviation
    • Maritime
    • Road Transportation
  • Employers
    • Large Enterprises
    • Small & Medium Enterprises
  • Individuals
  • Rehabilitation Centers
  • Follow-Up Testing
  • Post-Accident Testing
  • Pre-Employment Testing
  • Random Testing
  • Return-To-Duty Testing
  • Amphetamines
  • Barbiturates
  • Benzodiazepines
  • Cannabinoids
  • Cocaine
  • Opiates
  • Gas Chromatography-Mass Spectrometry (GC-MS)
  • High-Performance Liquid Chromatography (HPLC)
  • Immunoassay
  • FDA Approved Tests
  • Laboratory-Based Tests
  • Over-The-Counter
  • Female
  • Male
  • 0-17 Years
  • 18-35 Years
  • 36-55 Years
  • 56+ Years
  • Future Sub-Segmentation
    • Retirement Age (65+)
  • High Volume
  • Low Volume
  • Medium Volume
  • CAP Accreditation
  • CLIA Compliance
  • SAMHSA Certification

This research report categorizes the Drug Testing Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Drug Testing Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Alfa Scientific Designs, Inc.
  • Bio-Rad Laboratories, Inc.
  • Clinical Reference Laboratory, Inc.
  • Cordant Health Solutions
  • Drägerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche AG
  • Legacy Medical Services, LLC.
  • Omega Laboratories, Inc.
  • Quest Diagnostics
  • Quidel Corporation
  • Sciteck Clinical Laboratories
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Drug Testing Market, by Type Of Drug Test
8.1. Introduction
8.2. Blood Test
8.3. Hair Test
8.4. Saliva Test
8.5. Sweat Test
8.6. Urine Test
9. Drug Testing Market, by Industry
9.1. Introduction
9.2. Construction
9.3. Government And Law Enforcement
9.4. Healthcare
9.4.1. Clinics
9.4.2. Hospitals
9.5. Manufacturing
9.6. Sports
9.7. Transportation
9.7.1. Aviation
9.7.2. Maritime
9.7.3. Road Transportation
10. Drug Testing Market, by End User
10.1. Introduction
10.2. Employers
10.2.1. Large Enterprises
10.2.2. Small & Medium Enterprises
10.3. Individuals
10.4. Rehabilitation Centers
11. Drug Testing Market, by Purpose Of Testing
11.1. Introduction
11.2. Follow-Up Testing
11.3. Post-Accident Testing
11.4. Pre-Employment Testing
11.5. Random Testing
11.6. Return-To-Duty Testing
12. Drug Testing Market, by Drug Type
12.1. Introduction
12.2. Amphetamines
12.3. Barbiturates
12.4. Benzodiazepines
12.5. Cannabinoids
12.6. Cocaine
12.7. Opiates
13. Drug Testing Market, by Testing Technology
13.1. Introduction
13.2. Gas Chromatography-Mass Spectrometry (GC-MS)
13.3. High-Performance Liquid Chromatography (HPLC)
13.4. Immunoassay
14. Drug Testing Market, by Testing Channel
14.1. Introduction
14.2. FDA Approved Tests
14.3. Laboratory-Based Tests
14.4. Over-The-Counter
15. Drug Testing Market, by Gender
15.1. Introduction
15.2. Female
15.3. Male
16. Drug Testing Market, by Age Group
16.1. Introduction
16.2. 0-17 Years
16.3. 18-35 Years
16.4. 36-55 Years
16.5. 56+ Years
16.6. Future Sub-Segmentation
16.6.1. Retirement Age (65+)
17. Drug Testing Market, by Sample Volume
17.1. Introduction
17.2. High Volume
17.3. Low Volume
17.4. Medium Volume
18. Drug Testing Market, by Certification And Standards
18.1. Introduction
18.2. CAP Accreditation
18.3. CLIA Compliance
18.4. SAMHSA Certification
19. Americas Drug Testing Market
19.1. Introduction
19.2. Argentina
19.3. Brazil
19.4. Canada
19.5. Mexico
19.6. United States
20. Asia-Pacific Drug Testing Market
20.1. Introduction
20.2. Australia
20.3. China
20.4. India
20.5. Indonesia
20.6. Japan
20.7. Malaysia
20.8. Philippines
20.9. Singapore
20.10. South Korea
20.11. Taiwan
20.12. Thailand
20.13. Vietnam
21. Europe, Middle East & Africa Drug Testing Market
21.1. Introduction
21.2. Denmark
21.3. Egypt
21.4. Finland
21.5. France
21.6. Germany
21.7. Israel
21.8. Italy
21.9. Netherlands
21.10. Nigeria
21.11. Norway
21.12. Poland
21.13. Qatar
21.14. Russia
21.15. Saudi Arabia
21.16. South Africa
21.17. Spain
21.18. Sweden
21.19. Switzerland
21.20. Turkey
21.21. United Arab Emirates
21.22. United Kingdom
22. Competitive Landscape
22.1. Market Share Analysis, 2024
22.2. FPNV Positioning Matrix, 2024
22.3. Competitive Analysis
22.3.1. Abbott Laboratories
22.3.2. Agilent Technologies, Inc.
22.3.3. Alfa Scientific Designs, Inc.
22.3.4. Bio-Rad Laboratories, Inc.
22.3.5. Clinical Reference Laboratory, Inc.
22.3.6. Cordant Health Solutions
22.3.7. Drägerwerk AG & Co. KGaA
22.3.8. F. Hoffmann-La Roche AG
22.3.9. Legacy Medical Services, LLC.
22.3.10. Omega Laboratories, Inc.
22.3.11. Quest Diagnostics
22.3.12. Quidel Corporation
22.3.13. Sciteck Clinical Laboratories
22.3.14. Siemens Healthineers AG
22.3.15. Thermo Fisher Scientific Inc.
23. ResearchAI
24. ResearchStatistics
25. ResearchContacts
26. ResearchArticles
27. Appendix
List of Figures
FIGURE 1. DRUG TESTING MARKET MULTI-CURRENCY
FIGURE 2. DRUG TESTING MARKET MULTI-LANGUAGE
FIGURE 3. DRUG TESTING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DRUG TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DRUG TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DRUG TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DRUG TESTING MARKET SIZE, BY TYPE OF DRUG TEST, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DRUG TESTING MARKET SIZE, BY TYPE OF DRUG TEST, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DRUG TESTING MARKET SIZE, BY INDUSTRY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DRUG TESTING MARKET SIZE, BY INDUSTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DRUG TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DRUG TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DRUG TESTING MARKET SIZE, BY PURPOSE OF TESTING, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DRUG TESTING MARKET SIZE, BY PURPOSE OF TESTING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL DRUG TESTING MARKET SIZE, BY TESTING TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 18. GLOBAL DRUG TESTING MARKET SIZE, BY TESTING TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL DRUG TESTING MARKET SIZE, BY TESTING CHANNEL, 2024 VS 2030 (%)
FIGURE 20. GLOBAL DRUG TESTING MARKET SIZE, BY TESTING CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL DRUG TESTING MARKET SIZE, BY GENDER, 2024 VS 2030 (%)
FIGURE 22. GLOBAL DRUG TESTING MARKET SIZE, BY GENDER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GLOBAL DRUG TESTING MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 24. GLOBAL DRUG TESTING MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. GLOBAL DRUG TESTING MARKET SIZE, BY SAMPLE VOLUME, 2024 VS 2030 (%)
FIGURE 26. GLOBAL DRUG TESTING MARKET SIZE, BY SAMPLE VOLUME, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. GLOBAL DRUG TESTING MARKET SIZE, BY CERTIFICATION AND STANDARDS, 2024 VS 2030 (%)
FIGURE 28. GLOBAL DRUG TESTING MARKET SIZE, BY CERTIFICATION AND STANDARDS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. AMERICAS DRUG TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. AMERICAS DRUG TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. UNITED STATES DRUG TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 32. UNITED STATES DRUG TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 33. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 34. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 35. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 36. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 37. DRUG TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 38. DRUG TESTING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DRUG TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DRUG TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DRUG TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DRUG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DRUG TESTING MARKET SIZE, BY TYPE OF DRUG TEST, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DRUG TESTING MARKET SIZE, BY BLOOD TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DRUG TESTING MARKET SIZE, BY HAIR TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DRUG TESTING MARKET SIZE, BY SALIVA TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DRUG TESTING MARKET SIZE, BY SWEAT TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DRUG TESTING MARKET SIZE, BY URINE TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DRUG TESTING MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DRUG TESTING MARKET SIZE, BY CONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DRUG TESTING MARKET SIZE, BY GOVERNMENT AND LAW ENFORCEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DRUG TESTING MARKET SIZE, BY HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DRUG TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DRUG TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DRUG TESTING MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DRUG TESTING MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DRUG TESTING MARKET SIZE, BY SPORTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DRUG TESTING MARKET SIZE, BY TRANSPORTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DRUG TESTING MARKET SIZE, BY AVIATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DRUG TESTING MARKET SIZE, BY MARITIME, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DRUG TESTING MARKET SIZE, BY ROAD TRANSPORTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DRUG TESTING MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DRUG TESTING MARKET SIZE, BY EMPLOYERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DRUG TESTING MARKET SIZE, BY LARGE ENTERPRISES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DRUG TESTING MARKET SIZE, BY SMALL & MEDIUM ENTERPRISES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DRUG TESTING MARKET SIZE, BY EMPLOYERS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DRUG TESTING MARKET SIZE, BY INDIVIDUALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DRUG TESTING MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DRUG TESTING MARKET SIZE, BY PURPOSE OF TESTING, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DRUG TESTING MARKET SIZE, BY FOLLOW-UP TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DRUG TESTING MARKET SIZE, BY POST-ACCIDENT TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DRUG TESTING MARKET SIZE, BY PRE-EMPLOYMENT TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DRUG TESTING MARKET SIZE, BY RANDOM TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DRUG TESTING MARKET SIZE, BY RETURN-TO-DUTY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DRUG TESTING MARKET SIZE, BY AMPHETAMINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DRUG TESTING MARKET SIZE, BY BARBITURATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DRUG TESTING MARKET SIZE, BY BENZODIAZEPINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DRUG TESTING MARKET SIZE, BY CANNABINOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DRUG TESTING MARKET SIZE, BY COCAINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DRUG TESTING MARKET SIZE, BY OPIATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL DRUG TESTING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL DRUG TESTING MARKET SIZE, BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY (GC-MS), BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL DRUG TESTING MARKET SIZE, BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC), BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL DRUG TESTING MARKET SIZE, BY TESTING CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL DRUG TESTING MARKET SIZE, BY FDA APPROVED TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL DRUG TESTING MARKET SIZE, BY LABORATORY-BASED TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL DRUG TESTING MARKET SIZE, BY OVER-THE-COUNTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL DRUG TESTING MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL DRUG TESTING MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL DRUG TESTING MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL DRUG TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL DRUG TESTING MARKET SIZE, BY 0-17 YEARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL DRUG TESTING MARKET SIZE, BY 18-35 YEARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL DRUG TESTING MARKET SIZE, BY 36-55 YEARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL DRUG TESTING MARKET SIZE, BY 56+ YEARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL DRUG TESTING MARKET SIZE, BY FUTURE SUB-SEGMENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL DRUG TESTING MARKET SIZE, BY RETIREMENT AGE (65+), BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL DRUG TESTING MARKET SIZE, BY FUTURE SUB-SEGMENTATION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL DRUG TESTING MARKET SIZE, BY SAMPLE VOLUME, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL DRUG TESTING MARKET SIZE, BY HIGH VOLUME, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL DRUG TESTING MARKET SIZE, BY LOW VOLUME, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL DRUG TESTING MARKET SIZE, BY MEDIUM VOLUME, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL DRUG TESTING MARKET SIZE, BY CERTIFICATION AND STANDARDS, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL DRUG TESTING MARKET SIZE, BY CAP ACCREDITATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL DRUG TESTING MARKET SIZE, BY CLIA COMPLIANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL DRUG TESTING MARKET SIZE, BY SAMHSA CERTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS DRUG TESTING MARKET SIZE, BY TYPE OF DRUG TEST, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS DRUG TESTING MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS DRUG TESTING MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS DRUG TESTING MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS DRUG TESTING MARKET SIZE, BY EMPLOYERS, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS DRUG TESTING MARKET SIZE, BY PURPOSE OF TESTING, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS DRUG TESTING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS DRUG TESTING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS DRUG TESTING MARKET SIZE, BY TESTING CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS DRUG TESTING MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS DRUG TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS DRUG TESTING MARKET SIZE, BY FUTURE SUB-SEGMENTATION, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS DRUG TESTING MARKET SIZE, BY SAMPLE VOLUME, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS DRUG TESTING MARKET SIZE, BY CERTIFICATION AND STANDARDS, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS DRUG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA DRUG TESTING MARKET SIZE, BY TYPE OF DRUG TEST, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA DRUG TESTING MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA DRUG TESTING MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA DRUG TESTING MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA DRUG TESTING MARKET SIZE, BY EMPLOYERS, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA DRUG TESTING MARKET SIZE, BY PURPOSE OF TESTING, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA DRUG TESTING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA DRUG TESTING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA DRUG TESTING MARKET SIZE, BY TESTING CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA DRUG TESTING MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA DRUG TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA DRUG TESTING MARKET SIZE, BY FUTURE SUB-SEGMENTATION, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA DRUG TESTING MARKET SIZE, BY SAMPLE VOLUME, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA DRUG TESTING MARKET SIZE, BY CERTIFICATION AND STANDARDS, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL DRUG TESTING MARKET SIZE, BY TYPE OF DRUG TEST, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL DRUG TESTING MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL DRUG TESTING MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL DRUG TESTING MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL DRUG TESTING MARKET SIZE, BY EMPLOYERS, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL DRUG TESTING MARKET SIZE, BY PURPOSE OF TESTING, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL DRUG TESTING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL DRUG TESTING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL DRUG TESTING MARKET SIZE, BY TESTING CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL DRUG TESTING MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL DRUG TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL DRUG TESTING MARKET SIZE, BY FUTURE SUB-SEGMENTATION, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL DRUG TESTING MARKET SIZE, BY SAMPLE VOLUME, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL DRUG TESTING MARKET SIZE, BY CERTIFICATION AND STANDARDS, 2018-2030 (USD MILLION)
TABLE 119. CANADA DRUG TESTING MARKET SIZE, BY TYPE OF DRUG TEST, 2018-2030 (USD MILLION)
TABLE 120. CANADA DRUG TESTING MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 121. CANADA DRUG TESTING MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 122. CANADA DRUG TESTING MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 123. CANADA DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. CANADA DRUG TESTING MARKET SIZE, BY EMPLOYERS, 2018-2030 (USD MILLION)
TABLE 125. CANADA DRUG TESTING MARKET SIZE, BY PURPOSE OF TESTING, 2018-2030 (USD MILLION)
TABLE 126. CANADA DRUG TESTING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 127. CANADA DRUG TESTING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 128. CANADA DRUG TESTING MARKET SIZE, BY TESTING CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. CANADA DRUG TESTING MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 130. CANADA DRUG TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 131. CANADA DRUG TESTING MARKET SIZE, BY FUTURE SUB-SEGMENTATION, 2018-2030 (USD MILLION)
TABLE 132. CANADA DRUG TESTING MARKET SIZE, BY SAMPLE VOLUME, 2018-2030 (USD MILLION)
TABLE 133. CANADA DRUG TESTING MARKET SIZE, BY CERTIFICATION AND STANDARDS, 2018-2030 (USD MILLION)
TABLE 134. MEXICO DRUG TESTING MARKET SIZE, BY TYPE OF DRUG TEST, 2018-2030 (USD MILLION)
TABLE 135. MEXICO DRUG TESTING MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 136. MEXICO DRUG TESTING MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 137. MEXICO DRUG TESTING MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 138. MEXICO DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. MEXICO DRUG TESTING MARKET SIZE, BY EMPLOYERS, 2018-2030 (USD MILLION)
TABLE 140. MEXICO DRUG TESTING MARKET SIZE, BY PURPOSE OF TESTING, 2018-2030 (USD MILLION)
TABLE 141. MEXICO DRUG TESTING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 142. MEXICO DRUG TESTING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. MEXICO DRUG TESTING MARKET SIZE, BY TESTING CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. MEXICO DRUG TESTING MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 145. MEXICO DRUG TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 146. MEXICO DRUG TESTING MARKET SIZE, BY FUTURE SUB-SEGMENTATION, 2018-2030 (USD MILLION)
TABLE 147. MEXICO DRUG TESTING MARKET SIZE, BY SAMPLE VOLUME, 2018-2030 (USD MILLION)
TABLE 148. MEXICO DRUG TESTING MARKET SIZE, BY CERTIFICATION AND STANDARDS, 2018-2030 (USD MILLION)
TABLE 149. UNITED STATES DRUG TESTING MARKET SIZE, BY TYPE OF DRUG TEST, 2018-2030 (USD MILLION)
TABLE 150. UNITED STATES DRUG TESTING MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 151. UNITED STATES DRUG TESTING MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 152. UNITED STATES DRUG TESTING MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 153. UNITED STATES DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. UNITED STATES DRUG TESTING MARKET SIZE, BY EMPLOYERS, 2018-2030 (USD MILLION)
TABLE 155. UNITED STATES DRUG TESTING MARKET SIZE, BY PURPOSE OF TESTING, 2018-2030 (USD MILLION)
TABLE 156. UNITED STATES DRUG TESTING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 157. UNITED STATES DRUG TESTING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 158. UNITED STATES DRUG TESTING MARKET SIZE, BY TESTING CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. UNITED STATES DRUG TESTING MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 160. UNITED STATES DRUG TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 161. UNITED STATES DRUG TESTING MARKET SIZE, BY FUTURE SUB-SEGMENTATION, 2018-2030 (USD MILLION)
TABLE 162. UNITED STATES DRUG TESTING MARKET SIZE, BY SAMPLE VOLUME, 2018-2030 (USD MILLION)
TABLE 163. UNITED STATES DRUG TESTING MARKET SIZE, BY CERTIFICATION AND STANDARDS, 2018-2030 (USD MILLION)
TABLE 164. UNITED STATES DRUG TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 165. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY TYPE OF DRUG TEST, 2018-2030 (USD MILLION)
TABLE 166. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY EMPLOYERS, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY PURPOSE OF TESTING, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 174. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY TESTING CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 176. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 177. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY FUTURE SUB-SEGMENTATION, 2018-2030 (USD MILLION)
TABLE 178. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY SAMPLE VOLUME, 2018-2030 (USD MILLION)
TABLE 179. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY CERTIFICATION AND STANDARDS, 2018-2030 (USD MILLION)
TABLE 180. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 181. AUSTRALIA DRUG TESTING MARKET SIZE, BY TYPE OF DRUG TEST, 2018-2030 (USD MILLION)
TABLE 182. AUSTRALIA DRUG TESTING MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 183. AUSTRALIA DRUG TESTING MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 184. AUSTRALIA DRUG TESTING MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 185. AUSTRALIA DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. AUSTRALIA DRUG TESTING MARKET SIZE, BY EMPLOYERS, 2018-2030 (USD MILLION)
TABLE 187. AUSTRALIA DRUG TESTING MARKET SIZE, BY PURPOSE OF TESTING, 2018-2030 (USD MILLION)
TABLE 188. AUSTRALIA DRUG TESTING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 189. AUSTRALIA DRUG TESTING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 190. AUSTRALIA DRUG TESTING MARKET SIZE, BY TESTING CHANNEL, 2018-2030 (USD MILLION)
TABLE 191. AUSTRALIA DRUG TESTING MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 192. AUSTRALIA DRUG TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 193. AUSTRALIA DRUG TESTING MARKET SIZE, BY FUTURE SUB-SEGMENTATION, 2018-2030 (USD MILLION)
TABLE 194. AUSTRALIA DRUG TESTING MARKET SIZE, BY SAMPLE VOLUME, 2018-2030 (USD MILLION)
TABLE 195. AUSTRALIA DRUG TESTING MARKET SIZE, BY CERTIFICATION AND STANDARDS, 2018-2030 (USD MILLION)
TABLE 196. CHINA DRUG TESTING MARKET SIZE, BY TYPE OF DRUG TEST, 2018-2030 (USD MILLION)
TABLE 197. CHINA DRUG TESTING MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 198. CHINA DRUG TESTING MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 199. CHINA DRUG TESTING MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 200. CHINA DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. CHINA DRUG TESTING MARKET SIZE, BY EMPLOYERS, 2018-2030 (USD MILLION)
TABLE 202. CHINA DRUG TESTING MARKET SIZE, BY PURPOSE OF TESTING, 2018-2030 (USD MILLION)
TABLE 203. CHINA DRUG TESTING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 204. CHINA DRUG TESTING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 205. CHINA DRUG TESTING MARKET SIZE, BY TESTING CHANNEL, 2018-2030 (USD MILLION)
TABLE 206. CHINA DRUG TESTING MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 207. CHINA DRUG TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 208. CHINA DRUG TESTING MARKET SIZE, BY FUTURE SUB-SEGMENTATION, 2018-2030 (USD MILLION)
TABLE 209. CHINA DRUG TESTING MARKET SIZE, BY SAMPLE VOLUME, 2018-2030 (USD MILLION)
TABLE 210. CHINA DRUG TESTING MARKET SIZE, BY CERTIFICATION AND STANDARDS, 2018-2030 (USD MILLION)
TABLE 211. INDIA DRUG TESTING MARKET SIZE, BY TYPE OF DRUG TEST, 2018-2030 (USD MILLION)
TABLE 212. INDIA DRUG TESTING MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 213. INDIA DRUG TESTING MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 214. INDIA DRUG TESTING MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 215. INDIA DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. INDIA DRUG TESTING MARKET SIZE, BY EMPLOYERS, 2018-2030 (USD MILLION)
TABLE 217. INDIA DRUG TESTING MARKET SIZE, BY PURPOSE OF TESTING, 2018-2030 (USD MILLION)
TABLE 218. INDIA DRUG TESTING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 219. INDIA DRUG TESTING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 220. INDIA DRUG TESTING MARKET SIZE, BY TESTING CHANNEL, 2018-2030 (USD MILLION)
TABLE 221. INDIA DRUG TESTING MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 222. INDIA DRUG TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 223. INDIA DRUG TESTING MARKET SIZE, BY FUTURE SUB-SEGMENTATION, 2018-2030 (USD MILLION)
TABLE 224. INDIA DRUG TESTING MARKET SIZE, BY SAMPLE VOLUME, 2018-2030 (USD MILLION)
TABLE 225. INDIA DRUG TESTING MARKET SIZE, BY CERTIFICATION AND STANDARDS, 2018-2030 (USD MILLION)
TABLE 226. INDONESIA DRUG TESTING MARKET SIZE, BY TYPE OF DRUG TEST, 2018-2030 (USD MILLION)
TABLE 227. INDONESIA DRUG TESTING MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 228. INDONESIA DRUG TESTING MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 229. INDONESIA DRUG TESTING MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 230. INDONESIA DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. INDONESIA DRUG TESTING MARKET SIZE, BY EMPLOYERS, 2018-2030 (USD MILLION)
TABLE 232. INDONESIA DRUG TESTING MARKET SIZE, BY PURPOSE OF TESTING, 2018-2030 (USD MILLION)
TABLE 233. INDONESIA DRUG TESTING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 234. INDONESIA DRUG TESTING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 235. INDONESIA DRUG TESTING MARKET SIZE, BY TESTING CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. INDONESIA DRUG TESTING MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 237. INDONESIA DRUG TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 238. INDONESIA DRUG TESTING MARKET SIZE, BY FUTURE SUB-SEGMENTATION, 2018-2030 (USD MILLION)
TABLE 239. INDONESIA DRUG TESTING MARKET SIZE, BY SAMPLE VOLUME, 2018-2030 (USD MILLION)
TABLE 240. INDONESIA DRUG TESTING MARKET SIZE, BY CERTIFICATION AND STANDARDS, 2018-2030 (USD MILLION)
TABLE 241. JAPAN DRUG TESTING MARKET SIZE, BY TYPE OF DRUG TEST, 2018-2030 (USD MILLION)
TABLE 242. JAPAN DRUG TESTING MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 243. JAPAN DRUG TESTING MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 244. JAPAN DRUG TESTING MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 245. JAPAN DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. JAPAN DRUG TESTING MARKET SIZE, BY EMPLOYERS, 2018-2030 (USD MILLION)
TABLE 247. JAPAN DRUG TESTING MARKET SIZE, BY PURPOSE OF TESTING, 2018-2030 (USD MILLION)
TABLE 248. JAPAN DRUG TESTING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 249. JAPAN DRUG TESTING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 250. JAPAN DRUG TESTING MARKET SIZE, BY TESTING CHANNEL, 2018-2030 (USD MILLION)
TABLE 251. JAPAN DRUG TESTING MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 252. JAPAN DRUG TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 253. JAPAN DRUG TESTING MARKET SIZE, BY FUTURE SUB-SEGMENTATION, 2018-2030 (USD MILLION)
TABLE 254. JAPAN DRUG TESTING MARKET SIZE, BY SAMPLE VOLUME, 2018-2030 (USD MILLION)
TABLE 255. JAPAN DRUG TESTING MARKET SIZE, BY CERTIFICATION AND STANDARDS, 2018-2030 (USD MILLION)
TABLE 256. MALAYSIA DRUG TESTING MARKET SIZE, BY TYPE OF DRUG TEST, 2018-2030 (USD MILLION)
TABLE 257. MALAYSIA DRUG TESTING MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 258. MALAYSIA DRUG TESTING MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 259. MALAYSIA DRUG TESTING MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 260. MALAYSIA DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. MALAYSIA DRUG TESTING MARKET SIZE, BY EMPLOYERS, 2018-2030 (USD MILLION)
TABLE 262. MALAYSIA DRUG TESTING MARKET SIZE, BY PURPOSE OF TESTING, 2018-2030 (USD MILLION)
TABLE 263. MALAYSIA DRUG TESTING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 264. MALAYSIA DRUG TESTING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 265. MALAYSIA DRUG TESTING MARKET SIZE, BY TESTING CHANNEL, 2018-2030 (USD MILLION)
TABLE 266. MALAYSIA DRUG TESTING MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 267. MALAYSIA DRUG TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 268. MALAYSIA DRUG TESTING MARKET SIZE, BY FUTURE SUB-SEGMENTATION, 2018-2030 (USD MILLION)
TABLE 269. MALAYSIA DRUG TESTING MARKET SIZE, BY SAMPLE VOLUME, 2018-2030 (USD MILLION)
TABLE 270. MALAYSIA DRUG TESTING MARKET SIZE, BY CERTIFICATION AND STANDARDS, 2018-2030 (USD MILLION)
TABLE 271. PHILIPPINES DRUG TESTING MARKET SIZE, BY TYPE OF DRUG TEST, 2018-2030 (USD MILLION)
TABLE 272. PHILIPPINES DRUG TESTING MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 273. PHILIPPINES DRUG TESTING MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 274. PHILIPPINES DRUG TESTING MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 275. PHILIPPINES DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. PHILIPPINES DRUG TESTING MARKET SIZE, BY EMPLOYERS, 2018-2030 (USD MILLION)
TABLE 277. PHILIPPINES DRUG TESTING MARKET SIZE, BY PURPOSE OF TESTING, 2018-2030 (USD MILLION)
TABLE 278. PHILIPPINES DRUG TESTING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 279. PHILIPPINES DRUG TESTING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 280. PHILIPPINES DRUG TESTING MARKET SIZE, BY TESTING CHANNEL, 2018-2030 (USD MILLION)
TABLE 281. PHILIPPINES DRUG TESTING MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 282. PHILIPPINES DRUG TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 283. PHILIPPINES DRUG TESTING MARKET SIZE, BY FUTURE SUB-SEGMENTATION, 2018-2030 (USD MILLION)
TABLE 284. PHILIPPINES DRUG TESTING MARKET SIZE, BY SAMPLE VOLUME, 2018-2030 (USD MILLION)
TABLE 285. PHILIPPINES DRUG TESTING MARKET SIZE, BY CERTIFICATION AND STANDARDS, 2018-2030 (USD MILLION)
TABLE 286. SINGAPORE DRUG TESTING MARKET SIZE, BY TYPE OF DRUG TEST, 2018-2030 (USD MILLION)
TABLE 287. SINGAPORE DRUG TESTING MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 288. SINGAPORE DRUG TESTING MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 289. SINGAPORE DRUG TESTING MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 290. SINGAPORE DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 291. SINGAPORE DRUG TESTING MARKET SIZE, BY EMPLOYERS, 2018-2030 (USD MILLION)
TABLE 292. SINGAPORE DRUG TESTING MARKET SIZE, BY PURPOSE OF TESTING, 2018-2030 (USD MILLION)
TABLE 293. SINGAPORE DRUG TESTING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 294. SINGAPORE DRUG TESTING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 295. SINGAPORE DRUG TESTING MARKET SIZE, BY TESTING CHANNEL, 2018-2030 (USD MILLION)
TABLE 296. SINGAPORE DRUG TESTING MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 297. SINGAPORE DRUG TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 298. SINGAPORE DRUG TESTING MARKET SIZE, BY FUTURE SUB-SEGMENTATION, 2018-2030 (USD MILLION)
TABLE 299. SINGAPORE DRUG TESTING MARKET SIZE, BY SAMPLE VOLUME, 2018-2030 (USD MILLION)
TABLE 300. SINGAPORE DRUG TESTING MARKET SIZE, BY CERTIFICATION AND STANDARDS, 2018-2030 (USD MILLION)
TABLE 301. SOUTH KOREA DRUG TESTING MARKET SIZE, BY TYPE OF DRUG TEST, 2018-2030 (USD MILLION)
TABLE 302. SOUTH KOREA DRUG TESTING MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 303. SOUTH KOREA DRUG TESTING MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 304. SOUTH KOREA DRUG TESTING MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 305. SOUTH KOREA DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 306. SOUTH KOREA DRUG TESTING MARKET SIZE, BY EMPLOYERS, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA DRUG TESTING MARKET SIZE, BY PURPOSE OF TESTING, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA DRUG TESTING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA DRUG TESTING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 310. SOUTH KOREA DRUG TESTING MARKET SIZE, BY TESTING CHANNEL, 2018-2030 (USD MILLION)
TABLE 311. SOUTH KOREA DRUG TESTING MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 312. SOUTH KOREA DRUG TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 313. SOUTH KOREA DRUG TESTING MARKET SIZE, BY FUTURE SUB-SEGMENTATION, 2018-2030 (USD MILLION)
TABLE 314. SOUTH KOREA DRUG TESTING MARKET SIZE, BY SAMPLE VOLUME, 2018-2030 (USD MILLION)
TABLE 315. SOUTH KOREA DRUG TESTING MARKET SIZE, BY CERTIFICATION AND STANDARDS, 2018-2030 (USD MILLION)
TABLE 316. TAIWAN DRUG TESTING MARKET SIZE, BY TYPE OF DRUG TEST, 2018-2030 (USD MILLION)
TABLE 317. TAIWAN DRUG TESTING MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 318. TAIWAN DRUG TESTING MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 319. TAIWAN DRUG TESTING MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 320. TAIWAN DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 321. TAIWAN DRUG TESTING MARKET SIZE, BY EMPLOYERS, 2018-2030 (USD MILLION)
TABLE 322. TAIWAN DRUG TESTING MARKET SIZE, BY PURPOSE OF TESTING, 2018-2030 (USD MILLION)
TABLE 323. TAIWAN DRUG TESTING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 324. TAIWAN DRUG TESTING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 325. TAIWAN DRUG TESTING MARKET SIZE, BY TESTING CHANNEL, 2018-2030 (USD MILLION)
TABLE 326. TAIWAN DRUG TESTING MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 327. TAIWAN DRUG TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 328. TAIWAN DRUG TESTING MARKET SIZE, BY FUTURE SUB-SEGMENTATION, 2018-2030 (USD MILLION)
TABLE 329. TAIWAN DRUG TESTING MARKET SIZE, BY SAMPLE VOLUME, 2018-2030 (USD MILLION)
TABLE 330. TAIWAN DRUG TESTING MARKET SIZE, BY CERTIFICATION AND STANDARDS, 2018-2030 (USD MILLION)
TABLE 331. THAILAND DRUG TESTING MARKET SIZE, BY TYPE OF DRUG TEST, 2018-2030 (USD MILLION)
TABLE 332. THAILAND DRUG TESTING MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 333. THAILAND DRUG TESTING MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 334. THAILAND DRUG TESTING MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 335. THAILAND DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 336. THAILAND DRUG TESTING MARKET SIZE, BY EMPLOYERS, 2018-2030 (USD MILLION)
TABLE 337. THAILAND DRUG TESTING MARKET SIZE, BY PURPOSE OF TESTING, 2018-2030 (USD MILLION)
TABLE 338. THAILAND DRUG TESTING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 339. THAILAND DRUG TESTING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 340. THAILAND DRUG TESTING MARKET SIZE, BY TESTING CHANNEL, 2018-2030 (USD MILLION)
TABLE 341. THAILAND DRUG TESTING MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 342. THAILAND DRUG TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 343. THAILAND DRUG TESTING MARKET SIZE, BY FUTURE SUB-SEGMENTATION, 2018-2030 (USD MILLION)
TABLE 344. THAILAND DRUG TESTING MARKET SIZE, BY SAMPLE VOLUME, 2018-2030 (USD MILLION)
TABLE 345. THAILAND DRUG TESTING MARKET SIZE, BY CERTIFICATION AND STANDARDS, 2018-2030 (USD MILLION)
TABLE 346. VIETNAM DRUG TESTING MARKET SIZE, BY TYPE OF DRUG TEST, 2018-2030 (USD MILLION)
TABLE 347. VIETNAM DRUG TESTING MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 348. VIETNAM DRUG TESTING MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 349. VIETNAM DRUG TESTING MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 350. VIETNAM DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 351. VIETNAM DRUG TESTING MARKET SIZE, BY EMPLOYERS, 2018-2030 (USD MILLION)
TABLE 352. VIETNAM DRUG TESTING MARKET SIZE, BY PURPOSE OF TESTING, 2018-2030 (USD MILLION)
TABLE 353. VIETNAM DRUG TESTING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 354. VIETNAM DRUG TESTING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 355. VIETNAM DRUG TESTING MARKET SIZE, BY TESTING CHANNEL, 2018-2030 (USD MILLION)
TABLE 356. VIETNAM DRUG TESTING MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 357. VIETNAM DRUG TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 358. VIETNAM DRUG TESTING MARKET SIZE, BY FUTURE SUB-SEGMENTATION, 2018-2030 (USD MILLION)
TABLE 359. VIETNAM DRUG TESTING MARKET SIZE, BY SAMPLE VOLUME, 2018-2030 (USD MILLION)
TABLE 360. VIETNAM DRUG TESTING MARKET SIZE, BY CERTIFICATION AND STANDARDS, 2018-2030 (USD MILLION)
TABLE 361. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY TYPE OF DRUG TEST, 2018-2030 (USD MILLION)
TABLE 362. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 363. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 364. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 365. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 366. EUROPE, MIDDLE EAST & AFRICA DRUG TES

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Alfa Scientific Designs, Inc.
  • Bio-Rad Laboratories, Inc.
  • Clinical Reference Laboratory, Inc.
  • Cordant Health Solutions
  • Drägerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche AG
  • Legacy Medical Services, LLC.
  • Omega Laboratories, Inc.
  • Quest Diagnostics
  • Quidel Corporation
  • Sciteck Clinical Laboratories
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Drug of Abuse Testing Market by Component, Sample Type, End User - Global Forecast 2025-2030 - Product Image

Drug of Abuse Testing Market by Component, Sample Type, End User - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Employer and Workplace Drug Testing Market Size, Share and Trends Analysis Report by Type, Product, Mode, Drug, End-use, and Region 2024-2030 - Product Image

Employer and Workplace Drug Testing Market Size, Share and Trends Analysis Report by Type, Product, Mode, Drug, End-use, and Region 2024-2030

  • Report
  • 120 Pages
  • Global
From
At-home Drug of Abuse Testing Market by Product, Test Type, Drug, Distribution Channel - Global Forecast 2025-2030 - Product Image

At-home Drug of Abuse Testing Market by Product, Test Type, Drug, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Drug Testing Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Sample (Urine Samples), By Drug (Alcohol, Opioids), By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Drug Testing Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Sample (Urine Samples), By Drug (Alcohol, Opioids), By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Drug Screening Market by Product (Rapid Testing (Urine, Oral), Analytical (Breathalyzer, Immunoassay, Chromatography)), Sample (Urine, Breath, Hair), Drug (Alcohol, Cannabis, Opioids), End User (Workplace, Hospital, Law) - Forecast to 2029 - Product Image

Drug Screening Market by Product (Rapid Testing (Urine, Oral), Analytical (Breathalyzer, Immunoassay, Chromatography)), Sample (Urine, Breath, Hair), Drug (Alcohol, Cannabis, Opioids), End User (Workplace, Hospital, Law) - Forecast to 2029

  • Report
  • 505 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.